Pathological Roles of Prostaglandin E2-specific E-type Prostanoid Receptors in Hormone-sensitive and Castration-resistant Prostate Cancer

Yasuyoshi Miyata,Masahito Masato,Yuta Mukae,Yuichiro Nakamura,Tsuyoshi Matsuda,Junki Harada,Kensuke Mitsunari,Tomohiro Matsuo,Kojiro Ohba,Hideki Sakai,YASUYOSHI MIYATA,MASAHITO MASATO,YUTA MUKAE,YUICHIRO NAKAMURA,TSUYOSHI MATSUDA,JUNKI HARADA,KENSUKE MITSUNARI,TOMOHIRO MATSUO,KOJIRO OHBA,HIDEKI SAKAI
DOI: https://doi.org/10.21873/anticanres.15238
2021-09-01
Anticancer Research
Abstract:BACKGROUND/AIM: Prostaglandin (PG) E<sub>2</sub> mediates malignant aggressiveness by binding to four specific E-type prostanoid receptors (EP1R - 4R). This study aimed to clarify the pathological significance of EPRs in hormone-sensitive prostate cancer (HSPC) and castration-resistant prostate cancer (CRPC).MATERIALS AND METHODS: EP1R - 4R expression was examined in 102 HSPC and 27 CRPC specimens. The relationships between their expression and proliferation index (PI), apoptotic index (AI), and vascular endothelial growth factor (VEGF)-A expression were analyzed.RESULTS: EP4R expression in CRPC was significantly higher compared to that in HSPC, even in advanced disease (T3/4, N1, and/or M1). EP4R expression was significantly correlated with PI, AI, and VEGF-A expression in CRPC. Such significant relationships were not detected between EP1R - 3R and CRPC.CONCLUSION: EP4R expression in CRPC was significantly higher than that in HSPC and was associated with cancer cell proliferation, apoptosis, and pro-angiogenetic potential.
oncology
What problem does this paper attempt to address?